Probing the functional impact of sequence variation on p53-DNA interactions using a novel microsphere assay for protein-DNA binding with human cell extracts.

The p53 tumor suppressor regulates its target genes through sequence-specific binding to DNA response elements (REs). Although numerous p53 REs are established, the thousands more identified by bioinformatics are not easily subjected to comparative functional evaluation. To examine the relationship...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Maher A Noureddine, Daniel Menendez, Michelle R Campbell, Omari J Bandele, Monica M Horvath, Xuting Wang, Gary S Pittman, Brian N Chorley, Michael A Resnick, Douglas A Bell
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2009
Materias:
Acceso en línea:https://doaj.org/article/c25bbce90e3945b88637a8ae0d552b94
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c25bbce90e3945b88637a8ae0d552b94
record_format dspace
spelling oai:doaj.org-article:c25bbce90e3945b88637a8ae0d552b942021-12-02T20:03:10ZProbing the functional impact of sequence variation on p53-DNA interactions using a novel microsphere assay for protein-DNA binding with human cell extracts.1553-73901553-740410.1371/journal.pgen.1000462https://doaj.org/article/c25bbce90e3945b88637a8ae0d552b942009-05-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19424414/?tool=EBIhttps://doaj.org/toc/1553-7390https://doaj.org/toc/1553-7404The p53 tumor suppressor regulates its target genes through sequence-specific binding to DNA response elements (REs). Although numerous p53 REs are established, the thousands more identified by bioinformatics are not easily subjected to comparative functional evaluation. To examine the relationship between RE sequence variation -- including polymorphisms -- and p53 binding, we have developed a multiplex format microsphere assay of protein-DNA binding (MAPD) for p53 in nuclear extracts. Using MAPD we measured sequence-specific p53 binding of doxorubicin-activated or transiently expressed p53 to REs from established p53 target genes and p53 consensus REs. To assess the sensitivity and scalability of the assay, we tested 16 variants of the p21 target sequence and a 62-multiplex set of single nucleotide (nt) variants of the p53 consensus sequence and found many changes in p53 binding that are not captured by current computational binding models. A group of eight single nucleotide polymorphisms (SNPs) was examined and binding profiles closely matched transactivation capability tested in luciferase constructs. The in vitro binding characteristics of p53 in nuclear extracts recapitulated the cellular in vivo transactivation capabilities for eight well-established human REs measured by luciferase assay. Using a set of 26 bona fide REs, we observed distinct binding patterns characteristic of transiently expressed wild type and mutant p53s. This microsphere assay system utilizes biologically meaningful cell extracts in a multiplexed, quantitative, in vitro format that provides a powerful experimental tool for elucidating the functional impact of sequence polymorphism and protein variation on protein/DNA binding in transcriptional networks.Maher A NoureddineDaniel MenendezMichelle R CampbellOmari J BandeleMonica M HorvathXuting WangGary S PittmanBrian N ChorleyMichael A ResnickDouglas A BellPublic Library of Science (PLoS)articleGeneticsQH426-470ENPLoS Genetics, Vol 5, Iss 5, p e1000462 (2009)
institution DOAJ
collection DOAJ
language EN
topic Genetics
QH426-470
spellingShingle Genetics
QH426-470
Maher A Noureddine
Daniel Menendez
Michelle R Campbell
Omari J Bandele
Monica M Horvath
Xuting Wang
Gary S Pittman
Brian N Chorley
Michael A Resnick
Douglas A Bell
Probing the functional impact of sequence variation on p53-DNA interactions using a novel microsphere assay for protein-DNA binding with human cell extracts.
description The p53 tumor suppressor regulates its target genes through sequence-specific binding to DNA response elements (REs). Although numerous p53 REs are established, the thousands more identified by bioinformatics are not easily subjected to comparative functional evaluation. To examine the relationship between RE sequence variation -- including polymorphisms -- and p53 binding, we have developed a multiplex format microsphere assay of protein-DNA binding (MAPD) for p53 in nuclear extracts. Using MAPD we measured sequence-specific p53 binding of doxorubicin-activated or transiently expressed p53 to REs from established p53 target genes and p53 consensus REs. To assess the sensitivity and scalability of the assay, we tested 16 variants of the p21 target sequence and a 62-multiplex set of single nucleotide (nt) variants of the p53 consensus sequence and found many changes in p53 binding that are not captured by current computational binding models. A group of eight single nucleotide polymorphisms (SNPs) was examined and binding profiles closely matched transactivation capability tested in luciferase constructs. The in vitro binding characteristics of p53 in nuclear extracts recapitulated the cellular in vivo transactivation capabilities for eight well-established human REs measured by luciferase assay. Using a set of 26 bona fide REs, we observed distinct binding patterns characteristic of transiently expressed wild type and mutant p53s. This microsphere assay system utilizes biologically meaningful cell extracts in a multiplexed, quantitative, in vitro format that provides a powerful experimental tool for elucidating the functional impact of sequence polymorphism and protein variation on protein/DNA binding in transcriptional networks.
format article
author Maher A Noureddine
Daniel Menendez
Michelle R Campbell
Omari J Bandele
Monica M Horvath
Xuting Wang
Gary S Pittman
Brian N Chorley
Michael A Resnick
Douglas A Bell
author_facet Maher A Noureddine
Daniel Menendez
Michelle R Campbell
Omari J Bandele
Monica M Horvath
Xuting Wang
Gary S Pittman
Brian N Chorley
Michael A Resnick
Douglas A Bell
author_sort Maher A Noureddine
title Probing the functional impact of sequence variation on p53-DNA interactions using a novel microsphere assay for protein-DNA binding with human cell extracts.
title_short Probing the functional impact of sequence variation on p53-DNA interactions using a novel microsphere assay for protein-DNA binding with human cell extracts.
title_full Probing the functional impact of sequence variation on p53-DNA interactions using a novel microsphere assay for protein-DNA binding with human cell extracts.
title_fullStr Probing the functional impact of sequence variation on p53-DNA interactions using a novel microsphere assay for protein-DNA binding with human cell extracts.
title_full_unstemmed Probing the functional impact of sequence variation on p53-DNA interactions using a novel microsphere assay for protein-DNA binding with human cell extracts.
title_sort probing the functional impact of sequence variation on p53-dna interactions using a novel microsphere assay for protein-dna binding with human cell extracts.
publisher Public Library of Science (PLoS)
publishDate 2009
url https://doaj.org/article/c25bbce90e3945b88637a8ae0d552b94
work_keys_str_mv AT maheranoureddine probingthefunctionalimpactofsequencevariationonp53dnainteractionsusinganovelmicrosphereassayforproteindnabindingwithhumancellextracts
AT danielmenendez probingthefunctionalimpactofsequencevariationonp53dnainteractionsusinganovelmicrosphereassayforproteindnabindingwithhumancellextracts
AT michellercampbell probingthefunctionalimpactofsequencevariationonp53dnainteractionsusinganovelmicrosphereassayforproteindnabindingwithhumancellextracts
AT omarijbandele probingthefunctionalimpactofsequencevariationonp53dnainteractionsusinganovelmicrosphereassayforproteindnabindingwithhumancellextracts
AT monicamhorvath probingthefunctionalimpactofsequencevariationonp53dnainteractionsusinganovelmicrosphereassayforproteindnabindingwithhumancellextracts
AT xutingwang probingthefunctionalimpactofsequencevariationonp53dnainteractionsusinganovelmicrosphereassayforproteindnabindingwithhumancellextracts
AT garyspittman probingthefunctionalimpactofsequencevariationonp53dnainteractionsusinganovelmicrosphereassayforproteindnabindingwithhumancellextracts
AT briannchorley probingthefunctionalimpactofsequencevariationonp53dnainteractionsusinganovelmicrosphereassayforproteindnabindingwithhumancellextracts
AT michaelaresnick probingthefunctionalimpactofsequencevariationonp53dnainteractionsusinganovelmicrosphereassayforproteindnabindingwithhumancellextracts
AT douglasabell probingthefunctionalimpactofsequencevariationonp53dnainteractionsusinganovelmicrosphereassayforproteindnabindingwithhumancellextracts
_version_ 1718375684778229760